Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves’ orbitopathy

OBJECTIVE: A combination of glucocorticoids with mycophenolate is recommended by current guidelines to boost response to Graves’ orbitopathy (GO) therapy. This study was designed to evaluate the therapeutic effects and safety of methotrexate (MTX) plus reduced (3.0 g) or full-dose (4.5 g) i.v. methy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Liyun, Ye, Lei, Zhu, Wei, Jiao, Qin, Zhou, Yulin, Wang, Shu, Wang, Weiqing, Ning, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422237/
https://www.ncbi.nlm.nih.gov/pubmed/35900774
http://dx.doi.org/10.1530/ETJ-22-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422237/
https://www.ncbi.nlm.nih.gov/pubmed/35900774
http://dx.doi.org/10.1530/ETJ-22-0017

Ejemplares similares